Stefano De Luca

About

Stefano De Luca is a leading urologic surgeon and researcher whose work centers on advancing precision and outcomes in prostate cancer surgery, particularly through robot-assisted radical prostatectomy (RARP). His most significant contribution is the development and validation of the "total anatomical reconstruction" (TAR) technique, a standardized approach that dramatically improves early recovery of urinary continence. This work, documented in his highly cited 2015 paper (136 citations) and validated across over 1,000 procedures (57 citations), has set a new benchmark for functional recovery. De Luca has also been instrumental in refining prostate cancer diagnostics, demonstrating through multiple studies (including a 49-citation paper) that multiparametric MRI fusion targeted biopsy provides superior Gleason score agreement with surgical pathology compared to standard biopsy. His research further explores innovative technologies, from the use of chitosan membranes to enhance nerve-sparing outcomes and potency recovery, to the role of MRI in guiding pelvic lymph node dissection. With over 500 total citations, De Luca’s work bridges cutting-edge surgical technique and diagnostic precision, directly improving patient quality of life and setting standards for the field.

Research Focus

Key Achievements

Top Papers

1. 1
   Total Anatomical Reconstruction During Robot-assisted Radical Prostatectomy: Implications on Early Recovery of Urinary Continence

   136 citations · 2015
2. 2
   Five-year Outcomes for a Prospective Randomised Controlled Trial Comparing Laparoscopic and Robot-assisted Radical Prostatectomy

   106 citations · 2016
3. 3
   Total anatomical reconstruction during robot‐assisted radical prostatectomy: focus on urinary continence recovery and related complications after 1000 procedures

   57 citations · 2019
4. 4
   Precision prostate cancer surgery: an overview of new technologies and techniques

   49 citations · 2019
5. 5
   Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score

   49 citations · 2016
6. 6
   In‐parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance

   42 citations · 2015
7. 7
   A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI

   25 citations · 2023
8. 8
   Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy

   22 citations · 2020
9. 9
   Use of chitosan membranes after nerve‐sparing radical prostatectomy improves early recovery of sexual potency: results of a comparative study

   15 citations · 2018
10. 10
    Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5%

    15 citations · 2018

Key Collaborators

Contact & Links